GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75F40120C00070RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH

Overview

Award facts

Net obligations
$831.96K
$831,964of $831.96K potential value
Outlays (paid to date)
$582.72K
$582.72K paid of $831.96K obligated$582,715
Period of performance
Aug 21, 2020 to Dec 28, 2022
Ended
Modifications
2
Latest action Jul 5, 2022
Contract type
Definitive contract
PIID 75F40120C00070

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

PROCUREMENT OF SERVICES IN SUPPORT OF THE PROJECT TITLED: OCT FOR REAL-TIME MONITORING OF COATING PROCESS DYNAMICS&PRODUCT QUALITY. REQUESTED.

Dates and value

Award date
Signed on Aug 21, 2020
Potential end of performance
Dec 27, 2022
Current value
$831,964Base and exercised options
Potential value (if all options are exercised)
$831,964

Obligations by fiscal year of action

  • FY2020: $831,964

Total across 1 fiscal year: $831,964

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 5, 2022. View on USAspending · Recipient on SAM.gov

Recipient

LocationGRAZ, AUT
UEIJMW6R9VB27L9
CAGE code5831N
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeInternational org

Business types and certifications

Nonprofit organizationInternational organization

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Human drugsProgram activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Austria

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
BAA-20-00123(as reported)
Solicitation date
May 25, 2020

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Contract financing
FAR 52.232-16 progress paymentsA
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 21, 2020Base obligation at award: $831,964
Latest action
Jul 5, 2022 — Other administrative actionModification P00003; administrative: no change in scope or value
Actions by type
  • Base award1
  • Other administrative action2
3 actions recorded, Aug 21, 2020 to Jul 5, 2022; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Critical functionsCT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business incorporated in the U.S.C
Country of product or service origin
AustriaAUT
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2020/2020-0600-000
Object classes
  • 41.0: Grants, subsidies, and contributions
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression